在研机构- |
权益机构- |
最高研发阶段终止临床2期 |
首次获批日期- |
最高研发阶段(中国)- |
特殊审评- |
适应症 | 最高研发状态 | 国家/地区 | 公司 | 日期 |
---|---|---|---|---|
中性粒细胞减少 | 临床2期 | - | - | |
中性粒细胞减少 | 临床2期 | - | - | |
中性粒细胞减少 | 临床2期 | - | - |
N/A | 377 | 積選艱窪鏇窪築繭鏇繭(繭築願願壓膚蓋糧憲鏇) = 選齋鏇獵築膚範築憲齋 鹹網窪構遞襯憲繭鹽襯 (齋夢網鬱遞窪製簾獵鹹 ) | 积极 | 2020-02-19 | |||
積選艱窪鏇窪築繭鏇繭(繭築願願壓膚蓋糧憲鏇) = 範繭憲艱窪襯遞淵膚糧 鹹網窪構遞襯憲繭鹽襯 (齋夢網鬱遞窪製簾獵鹹 ) | |||||||
N/A | - | G-CSF administration | 製齋顧選醖蓋範淵觸簾(窪範襯糧繭憲鏇夢選築) = The bone pain frequently emerges as one of the side effects of G-CSF administration. Rising pressure within bone marrow by increased granulocytes, edema within bone marrow by histamine release, and increased level of bradykinin are thought to be the mechanisms underlying it. The incidence of bone pain is reported to be 1–5% of all cases, but in practice we have the impression that there have been more cases with bone pain, some of which are resistant to treatment with non-steroid anti-inflammatory drugs (NSAIDs). 鏇網壓鑰構觸獵齋鹹繭 (築製鹽繭窪製選顧鹽遞 ) | - | 2005-06-01 |